Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lachelle D Weeks

Showing results (1-10 of 35) with videos related to

Pageof 4
Sort By:
Blood|February 27, 2025
Monitoring CH: time to move beyond VAF?Lachelle D Weeks
Seminars in Hematology|June 29, 2026
Clonal hematopoiesis in the setting of sickle cell disease and its relevance to curative therapiesLachelle D Weeks
The New England Journal of Medicine|April 23, 2025
Clonal Hematopoiesis as a Driver of Solid TumorsLachelle D Weeks, Benjamin L Ebert
British Journal of Haematology|December 9, 2024
Drafting a blueprint for designing successful clinical trials in clonal haematopoiesisShyam A Patel, Lachelle D Weeks
Blood|November 6, 2023
Causes and consequences of clonal hematopoiesisLachelle D Weeks, Benjamin L Ebert
Molecular Cancer Therapeutics|July 23, 2013
Uracil-DNA glycosylase expression determines human lung cancer cell sensitivity to pemetrexedLachelle D Weeks, Pingfu Fu, Stanton L Gerson
Blood|April 24, 2019
Monoclonal gammopathy of undetermined significanceTarek H Mouhieddine, Lachelle D Weeks, Irene M Ghobrial
Research and Practice in Thrombosis and Haemostasis|May 20, 2021
Management of therapeutic unfractionated heparin in COVID-19 patients: A retrospective cohort studyLachelle D Weeks, Katelyn W Sylvester, Jean M Connors, et al.
Blood Advances|August 4, 2025
Ethical Considerations for Hematologic Precursor ConditionsEric C Blackstone, Lachelle D Weeks, Amy E DeZern, et al.
Blood Advances|October 7, 2025
Myeloproliferative neoplasm subtypes have distinct impact on risk of incident osteoporosis and osteoporotic fracturesMichelle H Lee, Yating Wang, Angel M Cronin, et al.
Pageof 4

Showing results (1-10 of 35) with videos related to

Sort By:
Pageof 4
Blood|February 27, 2025
Monitoring CH: time to move beyond VAF?Lachelle D Weeks
Seminars in Hematology|June 29, 2026
Clonal hematopoiesis in the setting of sickle cell disease and its relevance to curative therapiesLachelle D Weeks
The New England Journal of Medicine|April 23, 2025
Clonal Hematopoiesis as a Driver of Solid TumorsLachelle D Weeks, Benjamin L Ebert
British Journal of Haematology|December 9, 2024
Drafting a blueprint for designing successful clinical trials in clonal haematopoiesisShyam A Patel, Lachelle D Weeks
Blood|November 6, 2023
Causes and consequences of clonal hematopoiesisLachelle D Weeks, Benjamin L Ebert
Molecular Cancer Therapeutics|July 23, 2013
Uracil-DNA glycosylase expression determines human lung cancer cell sensitivity to pemetrexedLachelle D Weeks, Pingfu Fu, Stanton L Gerson
Blood|April 24, 2019
Monoclonal gammopathy of undetermined significanceTarek H Mouhieddine, Lachelle D Weeks, Irene M Ghobrial
Research and Practice in Thrombosis and Haemostasis|May 20, 2021
Management of therapeutic unfractionated heparin in COVID-19 patients: A retrospective cohort studyLachelle D Weeks, Katelyn W Sylvester, Jean M Connors, et al.
Blood Advances|August 4, 2025
Ethical Considerations for Hematologic Precursor ConditionsEric C Blackstone, Lachelle D Weeks, Amy E DeZern, et al.
Blood Advances|October 7, 2025
Myeloproliferative neoplasm subtypes have distinct impact on risk of incident osteoporosis and osteoporotic fracturesMichelle H Lee, Yating Wang, Angel M Cronin, et al.
Pageof 4